Drug Metabolism Reviews
Volume 55, 2023 - Issue 4
Review Articles
Bioactivation and reactivity research advances – 2022 year in review‡
Shuai Wanga Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA, USACorrespondence[email protected]
https://orcid.org/0000-0002-3282-1343
https://orcid.org/0000-0002-3282-1343, Upendra A. Argikarb Non-clinical Development, Bill and Melinda Gates Medical Research Institute, Cambridge, MA, USAhttps://orcid.org/0000-0002-0939-0813
https://orcid.org/0000-0002-0939-0813, Lionel Cheruzela Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA, USAhttps://orcid.org/0000-0003-0283-6816
https://orcid.org/0000-0003-0283-6816, Sungjoon Choa Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA, USAhttps://orcid.org/0000-0003-1215-9759
https://orcid.org/0000-0003-1215-9759, Rachel D. Crouchc Department of Pharmacy and Pharmaceutical Sciences, Lipscomb University College of Pharmacy, Nashville, TN, USAhttps://orcid.org/0000-0002-4525-6072
https://orcid.org/0000-0002-4525-6072, Deepika Dhawared DMPK and Safety Sciences, Orion Pharma, Espoo, Finlandhttps://orcid.org/0009-0004-8628-8531
https://orcid.org/0009-0004-8628-8531, Carley J. S. Hecke Medicine Design, Pfizer Worldwide Research, Development and Medical, Groton, CT, USAhttps://orcid.org/0000-0002-6842-3670
https://orcid.org/0000-0002-6842-3670, Kevin M. Johnsonf Drug Metabolism and Pharmacokinetics, Inotiv, Maryland Heights, MO, USAhttps://orcid.org/0000-0003-0479-4242
https://orcid.org/0000-0003-0479-4242, Amit S. Kalgutkarg Medicine Design, Pfizer Worldwide Research, Development and Medical, Cambridge, MA, USAhttps://orcid.org/0000-0001-9701-756X
https://orcid.org/0000-0001-9701-756X, Lloyd Kingh Quantitative Drug Discovery, UCB Biopharma UK, Slough, UKhttps://orcid.org/0000-0002-3301-7533
https://orcid.org/0000-0002-3301-7533, Joyce Liua Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA, USAhttps://orcid.org/0009-0008-4667-6555
https://orcid.org/0009-0008-4667-6555, Bin Maa Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA, USAhttps://orcid.org/0000-0002-7549-2658
https://orcid.org/0000-0002-7549-2658, Hlaing Mawi Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USAhttps://orcid.org/0000-0002-4051-7958
https://orcid.org/0000-0002-4051-7958, Grover P. Millerj Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR, USAhttps://orcid.org/0000-0002-4743-8187
https://orcid.org/0000-0002-4743-8187, Herana Kamal Seneviratnek Department of Chemistry and Biochemistry, University of Maryland, Baltimore County, Baltimore, MD, USAhttps://orcid.org/0000-0002-7221-7060
https://orcid.org/0000-0002-7221-7060, Ryan H. Takahashil Denali Therapeutics, South San Francisco, CA, USAhttps://orcid.org/0000-0003-1016-0633
https://orcid.org/0000-0003-1016-0633, Cong Weim Drug Metabolism and Pharmacokinetics, Biogen Inc., Cambridge, MA, USAhttps://orcid.org/0000-0003-2310-9255
https://orcid.org/0000-0003-2310-9255 & S. Cyrus Khojasteha Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA, USACorrespondence[email protected]
https://orcid.org/0000-0002-8385-9288
https://orcid.org/0000-0002-8385-9288 show all